Bacterial L-forms in relapsing urinary-tract infection.
D000667:Ampicillin / Q000627:therapeutic use*; D001419:Bacteria / Q000254:growth & development; D002648:Child; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007740:L Forms / Q000187:drug effects / Q000254:growth & development; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy; D010403:Penicillin Resistance; D011239:Prednisolone / Q000627:therapeutic use; D011511:Proteus / Q000187:drug effects*; D011512:Proteus Infections / Q000188:drug therapy*; D013444:Sulfisoxazole / Q000627:therapeutic use*; D014546:Urinary Catheterization; D014552:Urinary Tract Infections / Q000150:complications* / Q000188:drug therapy*
D004917:Erythromycin; D013444:Sulfisoxazole; D000667:Ampicillin; D011239:Prednisolone